Video
Author(s):
As the number of treatment options for multiple sclerosis continues to grow patients and their doctors are left to find the right choice for them in order to manage the disease as successfully as possible. This can be a long process that can have a long lasting impact on their overall health.
With a wide variety of medications available and being developed for patients with multiple sclerosis the choices present different delivery options, dosing varieties, and other options. Alemtuzumab is another in this series of exciting developments in potential patient care.
Aaron L. Boster, MD, From OhioHealth Neurological Physicians discussed the treatment and finding the best treatment options avaialbe to patients during the annual ECTRIMS conference in Barcelona.
As the number of treatment options for multiple sclerosis continues to grow patients and their doctors are left to find the right choice for them in order to manage the disease as successfully as possible. This can be a long process that can have a long lasting impact on their overall health.
Real-World Study Confirms Similar Efficacy of Guselkumab and IL-17i for PsA